Filter
836
Text search:
Multidrug
resistant
tuberculosis
Featured
Recommendations
96
New Publications
205
Language
Document type
No document type
543
Studies & Reports
119
Guidelines
84
Manuals
29
Strategic & Response Plan
23
Fact sheets
18
Situation Updates
8
Training Material
7
Infographics
4
Videos
1
Countries / Regions
Western and Central Europe
53
Eastern Europe
39
India
33
South Africa
20
Kenya
18
Global
17
Ukraine
15
Tanzania
13
Asia
12
Malawi
11
Myanmar / Burma
11
Latin America and the Carribbean
11
Zambia
10
Namibia
10
Liberia
9
Ethiopia
9
South–East Asia Region
9
Rwanda
8
Bangladesh
8
Nigeria
7
Ghana
7
Nepal
7
Colombia
7
Russia
7
Uganda
6
Germany
6
Mozambique
6
Africa
6
Cambodia
5
Indonesia
5
Sierra Leone
4
Senegal
4
Congo, Democratic Republic of
4
Zimbabwe
4
Peru
4
Tajikistan
4
Philippines
3
Pakistan
3
Argentina
3
Eswatini/ Swaziland
3
Lesotho
3
Eastern Europe and Central Asia
3
Vietnam
3
Guinea
2
Burkina Faso
2
Papua New Guinea
2
Benin
2
El Salvador
2
Western Pacific Region
2
Armenia
2
Laos
2
Mali
1
Guinea-Bissau
1
Cameroon
1
South Sudan
1
Jordan
1
Afghanistan
1
Thailand
1
Gambia
1
Central African Republic
1
Switzerland
1
Ecuador
1
Botswana
1
Angola
1
Madagascar
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Paraguay
1
Bhutan
1
Estonia
1
Romania
1
Georgia
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
101
Public Health
30
Women & Child Health
13
Key Resources
12
Capacity Building
7
Pharmacy & Technologies
6
Toolboxes
TB
415
AMR
86
HIV
80
Refugee
20
Polio
16
Pharmacy
14
Ebola
12
COVID-19
12
Rapid Response
11
Global Health Education
8
NTDs
8
Conflict
6
Caregiver
6
Planetary Health
5
Health Financing Toolbox
5
Mental Health
4
NCDs
4
Natural Hazards
2
Disability
1
Accessed Febr. 6, 2020
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control.
...
World Health Organization, Food and Agriculture Organization of the United Nations & World Organisation for Animal Health. (2021). Antimicrobial resistance and the United Nations sustainable development cooperation framework: guidance for United Nations country teams. World Health Organization
...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex
...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
Public Health Situation Analysis and Interventions 10 October 2017
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po
...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally.
...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug
...
